A new obesity drug is producing twice as much weight loss as the current weight loss drugs on the market."Tesofensine – which inhibits the presynaptic uptake
of the neurotransmitters noradrenaline, dopamine and
serotonin in the brain – has been shown to be safe and effective
in animal models. It also caused unintended weight loss when
it was given obese patients with Parkinson's or Alzheimer's
disease when it was researched for those conditions. The drug
works by suppressing hunger, leading to an energy
deficit which burns off excess body fat. "
Unfortunately, it will still be a few years until
tesofenside will be launched in the world market.
For now, I will stick with good old-fashioned healthy
eating and exercise (that's my story and I'm sticking to it).
Click HERE for the full story.